Vitamin D–dependent induction of cathelicidin in human macrophages results in cytotoxicity against high-grade B cell lymphoma
暂无分享,去创建一个
A. Mackensen | D. Mougiakakos | R. Jitschin | B. Kempkes | C. Daniel | K. Amann | A. Hofmann | M. Fabri | J. Bittenbring | M. Hoffmann | F. Beier | F. Neumann | H. Bruns | M. Buettner | S. Pasemann | A. Gerbitz | Anna Maurberger | M. Büttner
[1] T. Thamboo,et al. Molecular profiling reveals a tumor-promoting phenotype of monocytes and macrophages in human cancer progression. , 2014, Immunity.
[2] M. Ziepert,et al. Vitamin D deficiency impairs rituximab-mediated cellular cytotoxicity and outcome of patients with diffuse large B-cell lymphoma treated with but not without rituximab. , 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[3] Tom C. Freeman,et al. Transcriptome-Based Network Analysis Reveals a Spectrum Model of Human Macrophage Activation , 2014, Immunity.
[4] P. Kubes,et al. Macrophages eliminate circulating tumor cells after monoclonal antibody therapy. , 2014, The Journal of clinical investigation.
[5] M. Ziepert,et al. 25-OH-Vitamin-D Deficiency Impairs Rituximab-Mediated Cellular Cytotoxicity and Is Associated With An Inferior Outcome Of Elderly DLBCL Patients Treated With Rituximab , 2013 .
[6] M. Zacharias,et al. Transformations in plasma membranes of cancerous cells and resulting consequences for cation insertion studied with molecular dynamics. , 2013, Physical chemistry chemical physics : PCCP.
[7] M. Fabri,et al. CD40 ligand and interferon‐γ induce an antimicrobial response against Mycobacterium tuberculosis in human monocytes , 2013, Immunology.
[8] M. Caligiuri,et al. NK cells impede glioblastoma virotherapy through NKp30 and NKp46 natural cytotoxicity receptors , 2012, Nature Medicine.
[9] G. Cheng,et al. Vitamin D Is Required for IFN-γ–Mediated Antimicrobial Activity of Human Macrophages , 2011, Science Translational Medicine.
[10] R. Bucki,et al. Real-time attack on single Escherichia coli cells by the human antimicrobial peptide LL-37 , 2011, Proceedings of the National Academy of Sciences.
[11] Drew A. Torigian,et al. CD40 Agonists Alter Tumor Stroma and Show Efficacy Against Pancreatic Carcinoma in Mice and Humans , 2011, Science.
[12] JoAnn E. Manson,et al. The 2011 Report on Dietary Reference Intakes for Calcium and Vitamin D from the Institute of Medicine: What Clinicians Need to Know , 2010, The Journal of clinical endocrinology and metabolism.
[13] J. Cerhan,et al. Vitamin D insufficiency and prognosis in non-Hodgkin's lymphoma. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[14] Bárbara Sousa,et al. Alterations in Vitamin D signalling and metabolic pathways in breast cancer progression: a study of VDR, CYP27B1 and CYP24A1 expression in benign and malignant breast lesions Vitamin D pathways unbalanced in breast lesions , 2010, BMC Cancer.
[15] Ash A. Alizadeh,et al. Anti-CD47 Antibody Synergizes with Rituximab to Promote Phagocytosis and Eradicate Non-Hodgkin Lymphoma , 2010, Cell.
[16] I. Weissman,et al. Macrophages as mediators of tumor immunosurveillance. , 2010, Trends in immunology.
[17] J. Trowbridge,et al. The Host Defense Peptide Cathelicidin Is Required for NK Cell-Mediated Suppression of Tumor Growth , 2009, The Journal of Immunology.
[18] G. Cheng,et al. Divergence of macrophage phagocytic and antimicrobial programs in leprosy. , 2009, Cell host & microbe.
[19] Uwe Rogel,et al. RNA extraction from archival formalin-fixed paraffin-embedded tissue: a comparison of manual, semiautomated, and fully automated purification methods. , 2009, Clinical chemistry.
[20] F. Marini,et al. The pro-inflammatory peptide LL-37 promotes ovarian tumor progression through recruitment of multipotent mesenchymal stromal cells , 2009, Proceedings of the National Academy of Sciences.
[21] Paul A Meyers,et al. Osteosarcoma: the addition of muramyl tripeptide to chemotherapy improves overall survival--a report from the Children's Oncology Group. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[22] G. Salles,et al. High numbers of tumor-associated macrophages have an adverse prognostic value that can be circumvented by rituximab in patients with follicular lymphoma enrolled onto the GELA-GOELAMS FL-2000 trial. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[23] M. Karjalainen‐Lindsberg,et al. A High Tumor-Associated Macrophage Content Predicts Favorable Outcome in Follicular Lymphoma Patients Treated with Rituximab and Cyclophosphamide-Doxorubicin-Vincristine-Prednisone , 2007, Clinical Cancer Research.
[24] N. Rothman,et al. Vitamin D receptor gene polymorphisms and risk of non-Hodgkin's lymphoma. , 2007, Haematologica.
[25] M. Uhrberg,et al. Resistance Against Natural Killer Cell Cytotoxicity: Analysis of Mechanisms , 2006, Scandinavian journal of immunology.
[26] Alberto Mantovani,et al. Tumour-associated macrophages are a distinct M2 polarised population promoting tumour progression: potential targets of anti-cancer therapy. , 2006, European journal of cancer.
[27] J. Adams,et al. Toll-Like Receptor Triggering of a Vitamin D-Mediated Human Antimicrobial Response , 2006, Science.
[28] P. Sinha,et al. Interleukin-13-regulated M2 macrophages in combination with myeloid suppressor cells block immune surveillance against metastasis. , 2005, Cancer research.
[29] R. Hancock,et al. Function and therapeutic potential of host defence peptides , 2005, Journal of peptide science : an official publication of the European Peptide Society.
[30] Karey Shumansky,et al. Analysis of multiple biomarkers shows that lymphoma-associated macrophage (LAM) content is an independent predictor of survival in follicular lymphoma (FL). , 2005, Blood.
[31] H. Koeffler,et al. Human cathelicidin antimicrobial peptide (CAMP) gene is a direct target of the vitamin D receptor and is strongly up‐regulated in myeloid cells by 1,25‐dihydroxyvitamin D3 , 2005, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[32] C. Gregory,et al. Enhanced Apoptotic Cell Clearance Capacity and B Cell Survival Factor Production by IL-10-Activated Macrophages: Implications for Burkitt’s Lymphoma1 , 2005, The Journal of Immunology.
[33] K. Haas,et al. The Innate Mononuclear Phagocyte Network Depletes B Lymphocytes through Fc Receptor–dependent Mechanisms during Anti-CD20 Antibody Immunotherapy , 2004, The Journal of experimental medicine.
[34] M. Zanetti. Cathelicidins, multifunctional peptides of the innate immunity , 2004, Journal of leukocyte biology.
[35] G. Salles,et al. Therapeutic activity of humanized anti-CD20 monoclonal antibody and polymorphism in IgG Fc receptor FcgammaRIIIa gene. , 2002, Blood.
[36] J. Calafat,et al. Human cathelicidin, hCAP-18, is processed to the antimicrobial peptide LL-37 by extracellular cleavage with proteinase 3. , 2001, Blood.
[37] T. Habermann,et al. Cd4+ T-cell immune response to large B-cell non-Hodgkin's lymphoma predicts patient outcome. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[38] P. Wallace,et al. Differential Effect of Cytokine Treatment on Fcα Receptor I- and Fcγ Receptor I-Mediated Tumor Cytotoxicity by Monocyte-Derived Macrophages , 2000, The Journal of Immunology.
[39] U. Weidle,et al. Control of cell growth by c-Myc in the absence of cell division , 1999, Current Biology.
[40] Y. Shai,et al. Structure and organization of the human antimicrobial peptide LL-37 in phospholipid membranes: relevance to the molecular basis for its non-cell-selective activity. , 1999, The Biochemical journal.
[41] R. Gennaro,et al. Cytotoxicity and apoptosis mediated by two peptides of innate immunity. , 1998, Cellular immunology.
[42] D. Lopez,et al. The altered tumoricidal capacity of macrophages isolated from tumor- bearing mice is related to reduce expression of the inducible nitric oxide synthase gene , 1996, The Journal of experimental medicine.
[43] R. Penny,et al. Bacillus Calmette-Guerin (BCG) enhances monocyte- and lymphocyte-mediated bladder tumour cell killing. , 1995, British Journal of Cancer.
[44] J. Peters,et al. 1,25‐Dihydroxyvitamin D3 Exerts Opposing Effects to IL‐4 on MHC Class‐II Antigen Expression, Accessory Activity, and Phagocytosis of Human Monocytes , 1993, Scandinavian journal of immunology.
[45] J. Uriel,et al. Receptor-mediated uptake and processing of vitamin D-binding protein in human B-lymphoid cells. , 1992, The Journal of biological chemistry.
[46] M. Cohen,et al. 1,25-Dihydroxyvitamin D3 activates secretion of hydrogen peroxide by human monocytes. , 1986, Journal of immunology.
[47] A. Morales,et al. INTRACAVITARY BACILLUS CALMETTE‐GUERIN IN THE TREATMENT OF SUPERFICIAL BLADDER TUMORS , 1976, The Journal of urology.
[48] D. Morton,et al. Immunological factors which influence response to immunotherapy in malignant melanoma. , 1970, Surgery.
[49] C. Morton,et al. What Clinicians Need to Know , 2006 .
[50] J. Pollard. Tumour-educated macrophages promote tumour progression and metastasis , 2004, Nature Reviews Cancer.